Status:

COMPLETED

Effect of a Uterine Manipulator on the Incidence of Lymphovascular Propagation (LVSI) in Treatment of Endometrial Cancer

Lead Sponsor:

F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica

Conditions:

Endometrial Cancer

LVSI

Eligibility:

FEMALE

Brief Summary

We retrospectively analyzed data and compared the impact of intrauterine manipulators on incidence of LVSI in endometrial cancer patients treated at our department.

Detailed Description

Endometrial cancers are among the epithelial malignancies of the lining in the uterine cavity. Standard treatment is surgical, which includes a hysterectomy. The invasion of carcinoma into the lymphov...

Eligibility Criteria

Inclusion

  • endometrioid endometrial cancer,
  • planned primary surgical treatment - hysterectomy,
  • medical condition enabling anesthesia and surgery,
  • pre-surgical clinically-determined affecting of the uterine according to MRI or ultrasound - cT1a or cT1b

Exclusion

  • non-endometrioid type of tumor in definitive histology,
  • stage 2 of a disease and higher,
  • previous chemo or radiotherapy,
  • inability to adequately complete the surgery,
  • uterine perforation during surgery

Key Trial Info

Start Date :

October 1 2015

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 1 2021

Estimated Enrollment :

170 Patients enrolled

Trial Details

Trial ID

NCT05261165

Start Date

October 1 2015

End Date

October 1 2021

Last Update

March 2 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

F.D. Roosevelt Teaching Hospital with Policlinic

Banská Bystrica, Slovakia